Last Updated: May 19, 2016
- Aligning policy to promote cascade genetic screening for prevention and early diagnosis of heritable diseases.
George Rani et al. Journal of genetic counseling 2015 Jun 24(3) 388-99 - An Integrative Genomic Analysis of Formalin Fixed Paraffin-Embedded Archived Serous Ovarian Carcinoma Comparing Long-term and Short-term Survivors.
Stålberg Karin, et al. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2016 5 - The Fanconi anemia DNA damage repair pathway in the spotlight for germline predisposition to colorectal cancer.
Esteban-Jurado Clara, et al. European journal of human genetics : EJHG 2016 5 - Genetic variants of lncRNA HOTAIR and risk of epithelial ovarian cancer among Chinese women.
Wu Haijing, et al. Oncotarget 2016 4 - Detection of somatic BRCA1/2 mutations in ovarian cancer - next-generation sequencing analysis of 100 cases.
Magdalena Koczkowska, et al. Cancer medicine 2016 5 - The rate of recurrent BRCA1, BRCA2, and TP53 mutations in the general population, and unselected ovarian cancer cases, in Belo Horizonte, Brazil.
Schayek Hagit, et al. Cancer genetics 2016 4 - Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast Cancer.
Maxwell Kara N et al. American journal of human genetics 2016 May 98(5) 801-17 - Ovarian cancer in BRCA1/2 mutation carriers: The impact of mutation position and family history on the cancer risk.
Teixeira Natalia et al. Maturitas 2015 Oct 82(2) 197-202 - JAX Genomics Education: Cancer Risk Assessment, Testing & Management
Disease: Lynch syndrome|Breast Cancer|Ovarian Cancer; Type: Education; State: Multiple States - Mutational analysis of FANCJ helicase.
Guo Manhong, et al. Methods (San Diego, Calif.) 2016 4 - Acceptance of, inclination for, and barriers in genetic testing for gene mutations that increase the risk of breast and ovarian cancers among female residents of Warsaw.
Olejniczak Dominik et al. Contemporary oncology (Poznan´, Poland) 2016 20(1) 80-5 - Parental Decision Making Regarding the Disclosure or Nondisclosure of a Mutation-Positive BRCA1/2 Test Result to Minors.
Seenandan-Sookdeo Kendra-Ann I et al. Oncology nursing forum 2016 May 43(3) 330-41 - A personalized paradigm in the treatment of platinum-resistant ovarian cancer - A cost utility analysis of genomic-based versus cytotoxic therapy.
Wallbillich J J et al. Gynecologic oncology 2016 Apr - Genetic Testing in Women With Ovarian Cancer Helps to Determine Prognosis,
by Chase Doyle, ASCO Post, April 25, 2016 - Ovarian cancer screening in menopausal females with a family history of breast or ovarian cancer.
Lai Tiffany et al. Journal of gynecologic oncology 2016 Apr e41 - HLA superfamily assignment is a predictor of immune response to cancer testis antigens and survival in ovarian cancer.
Szender J Brian, et al. Gynecologic oncology 2016 4 - Head-to-head comparison of the impact of Aurora A, Aurora B, Repp86, CDK1, CDK2 and Ki67 expression in two of the most relevant gynaecological tumor entities.
Heilmann Thorsten, et al. Archives of gynecology and obstetrics 2016 4 - Frequency of germline DNA genetic findings in an unselected prospective cohort of triple-negative breast cancer patients participating in a platinum-based neoadjuvant chemotherapy trial.
González-Rivera Milagros, et al. Breast cancer research and treatment 2016 4 (3) 507-15 - Assessing the genetic architecture of epithelial ovarian cancer histological subtypes.
Cuellar-Partida Gabriel, et al. Human genetics 2016 4 - A unified analytic framework for prioritization of non-coding variants of uncertain significance in heritable breast and ovarian cancer.
Mucaki Eliseos J, et al. BMC medical genomics 2016 0 (1) 19 - Single nucleotide polymorphisms in glutathione S-transferase P1 and M1 genes and overall survival of patients with ovarian serous cystadenocarcinoma treated with chemotherapy.
Cong Lan-Xiang, et al. Oncology letters 2016 4 (4) 2525-2531 - Association of single nucleotide polymorphisms in the MVP gene with platinum resistance and survival in patients with epithelial ovarian cancer.
Zhao Ya-Nan, et al. Oncology letters 2016 4 (4) 2925-2933 - Comprehensive analysis of lncRNA expression profiles reveals a novel lncRNA signature to discriminate nonequivalent outcomes in patients with ovarian cancer.
Zhou Meng, et al. Oncotarget 2016 4 - Olaparib maintenance therapy in patients with platinum-sensitive, relapsed serous ovarian cancer and a BRCA mutation: Overall survival adjusted for postprogression poly(adenosine diphosphate ribose) polymerase inhibitor therapy.
Matulonis Ursula A, et al. Cancer 2016 4 - Mutation detection rates associated with specific selection criteria for BRCA1/2 testing in 1854 high-risk families: A monocentric Italian study.
Azzollini Jacopo, et al. European journal of internal medicine 2016 4 - Decreased Expression of BRCA2 Accelerates Sporadic Breast Cancer Progression.
Saha Soumi, et al. Indian journal of surgical oncology 2015 12 (4) 378-83 - Canadian Women Encouraged to “Know Your Genes
Ovarian Cancer Canada, March 2016 - Know Your Genes: The Role Of Genetics In Ovarian Cancer
Huffington Post, April 13, 2016 - Know Your Genes: The Role Of Genetics In Ovarian Cancer,
Huffington Post, April 13, 2016 - Impact of Clinical Genetics Attendance at a Gynecologic Oncology Tumor Board on Referrals for Genetic Counseling and BRCA Mutation Testing.
Cohen Paul A et al. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2016 Apr
- Human (1443)
- Pathogen (0)
- Human (195)
- Pathogen (0)
.png)
No hay comentarios:
Publicar un comentario